Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case

Artículo de revista

Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case

Kenan TURGUTALP et al · Turkish Society of Nephrology · 2019

Acceso abierto al texto completo

Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Autor / responsable

Kenan TURGUTALP et al

Editorial

Turkish Society of Nephrology

Año

2019

ISSN

2667-4440

ISSN

2667-4440

Idioma

eng

Publicación seriada

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

Esta publicación seriada contiene 1.344 contenidos relacionados.

Ver contenidos

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto al texto completo

Texto completo identificado como acceso abierto.

Abrir texto

Resumen

Descripción general del contenido del recurso.

Olmesartan medoxomil (OM) is an angiotensin II receptor blocker (ARB) and it is used for the treatment of hypertension. Among all ARB drugs, only OM shows an angiotensin converting enzyme inhibitory effect (ACEI). OM may cause angioedema by its ARB effect. It can exhibit this role by the endogenous ACEI effect. While the frequency of angioedema associated with ACEI ranges from 0.1% to 1%, the frequency of ARB-induced angioedema is reported to range from 0.1% to 0.4%. A 38-year-old woman was diagnosed with primary hypertension and 20 mg/day OM was started for the management of hypertension. Following the second day of OM treatment, she was admitted to the emergency department because of a new episode of acute angioedema of the tongue, face and lips. OM induced angioedema was diagnosed. OM therapy was switched to a calcium channel blocker.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, K. T. E. (2019). Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case. https://turkjnephrol.org/index.php/pub/article/view/952

MLA

al, Kenan TURGUTALP et. "Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case." 2019. https://turkjnephrol.org/index.php/pub/article/view/952.

Chicago

al, Kenan TURGUTALP et. 2019. "Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case.". https://turkjnephrol.org/index.php/pub/article/view/952.

Harvard

al, K. T. E. 2019, Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case, Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/952 [Accessed 3 Jul. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

RIS BibTeX

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título: Is Olmesartan-Induced Angioedema Triggered by Angiotensin Converting Enzyme Inhibition and Kinin Peptides? A Rare Case

Autor / colaboradores: Kenan TURGUTALP et al

Editorial: Turkish Society of Nephrology

Año de publicación: 2019

ISSN: 2667-4440

ISSN: 2667-4440

Idioma: eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Olmesartan; Angioedema; Angiotensin-converting enzyme inhibitors